Healthcare Finance News November 11, 2024
Jeff Lagasse

The approach includes real-time analytics and specialty spend management capabilities.

Independent pharmacy benefit manager CerpassRx is looking to better manage specialty drug spend by teaming up with Waltz Health on an artificial intelligence-powered platform called Intelligent Specialty Engine.

The idea is that the approach, which includes real-time analytics and specialty spend management capabilities, will improve transparency and smooth the specialty drug experience for health plans and employers.

Data from the Assistant Secretary for Planning and Evaluation published in 2022 showed specialty drugs account for more than half of total drug spend. Health plans and self-insured employers are facing increasing pressure to manage these expenses more effectively, and in some cases are turning to PBMs.

WHAT’S THE IMPACT?

According to CarepassRx,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma, Pharma / Biotech, Technology
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Healthcare supply chain, pharmacy costs to rise in 2025: report
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
Behind Intermountain Health's in-house PBM

Share This Article